How Wearable Skin Patches Are Replacing Needles for Drug Delivery

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

How Wearable Skin Patches Are Replacing Needles for Drug Delivery

無料で聴く

ポッドキャストの詳細を見る

In this episode of The Digital Health Podcast, Lucas and Luna explore the emerging world of wearable microneedle patches that deliver drugs through the skin without pain. They focus on the specific case of Zosano Pharma's transdermal patch for migraine, which failed in clinical trials in 2021, and contrast it with newer players like Vaxxas and LTS Lohmann that are targeting vaccines and insulin. Lucas breaks down the key engineering challenge: how to make microneedles long enough to penetrate the stratum corneum but short enough to avoid pain receptors. Luna asks whether the FDA's regulatory pathway for combination products is slowing adoption. The hosts also discuss the potential market size: Grand View Research estimates the transdermal drug delivery market could reach $12.3 billion by 2027. They debate whether the biggest win will be in chronic disease management (insulin, GLP-1 agonists) or mass vaccination campaigns. The episode ties the conversation to listener support, noting that independent digital health journalism helps separate real innovation from hype. A focused, technical conversation for anyone interested in how wearables are moving beyond sensors into therapeutics. #DigitalHealth #WearableTech #MicroneedlePatches #DrugDelivery #Transdermal #ZosanoPharma #Vaxxas #LTSLohmann #Migraine #Insulin #GLP1 #FDA #CombinationProducts #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech Keep every episode free: buymeacoffee.com/fexingo

まだレビューはありません